ResMed Retained Earnings (Accumulated Deficit) 2010-2024 | RMD
ResMed retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- ResMed retained earnings (accumulated deficit) for the quarter ending December 31, 2024 were $5.492B, a 20.97% increase year-over-year.
- ResMed retained earnings (accumulated deficit) for 2024 were $4.992B, a 17.37% increase from 2023.
- ResMed retained earnings (accumulated deficit) for 2023 were $4.253B, a 17.69% increase from 2022.
- ResMed retained earnings (accumulated deficit) for 2022 were $3.614B, a 17.34% increase from 2021.
| ResMed Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $4,992 |
| 2023 | $4,253 |
| 2022 | $3,614 |
| 2021 | $3,080 |
| 2020 | $2,833 |
| 2019 | $2,436 |
| 2018 | $2,432 |
| 2017 | $2,316 |
| 2016 | $2,160 |
| 2015 | $1,976 |
| 2014 | $1,780 |
| 2013 | $1,577 |
| 2012 | $1,367 |
| 2011 | $1,112 |
| 2010 | $885 |
| 2009 | $695 |
| ResMed Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $5,492 |
| 2024-09-30 | $5,225 |
| 2024-06-30 | $4,992 |
| 2024-03-31 | $4,770 |
| 2023-12-31 | $4,540 |
| 2023-09-30 | $4,402 |
| 2023-06-30 | $4,253 |
| 2023-03-31 | $4,088 |
| 2022-12-31 | $3,920 |
| 2022-09-30 | $3,760 |
| 2022-06-30 | $3,614 |
| 2022-03-31 | $3,480 |
| 2021-12-31 | $3,363 |
| 2021-09-30 | $3,222 |
| 2021-06-30 | $3,080 |
| 2021-03-31 | $2,941 |
| 2020-12-31 | $3,077 |
| 2020-09-30 | $2,954 |
| 2020-06-30 | $2,833 |
| 2020-03-31 | $2,712 |
| 2019-12-31 | $2,605 |
| 2019-09-30 | $2,501 |
| 2019-06-30 | $2,436 |
| 2019-03-31 | $2,421 |
| 2018-12-31 | $2,368 |
| 2018-09-30 | $2,296 |
| 2018-06-30 | $2,432 |
| 2018-03-31 | $2,372 |
| 2017-12-31 | $2,312 |
| 2017-09-30 | $2,353 |
| 2017-06-30 | $2,316 |
| 2017-03-31 | $2,261 |
| 2016-12-31 | $2,220 |
| 2016-09-30 | $2,190 |
| 2016-06-30 | $2,160 |
| 2016-03-31 | $2,109 |
| 2015-12-31 | $2,063 |
| 2015-09-30 | $2,014 |
| 2015-06-30 | $1,976 |
| 2015-03-31 | $1,928 |
| 2014-12-31 | $1,876 |
| 2014-09-30 | $1,824 |
| 2014-06-30 | $1,780 |
| 2014-03-31 | $1,728 |
| 2013-12-31 | $1,673 |
| 2013-09-30 | $1,622 |
| 2013-06-30 | $1,577 |
| 2013-03-31 | $1,528 |
| 2012-12-31 | $1,467 |
| 2012-09-30 | $1,414 |
| 2012-06-30 | $1,367 |
| 2012-03-31 | $1,290 |
| 2011-12-31 | $1,225 |
| 2011-09-30 | $1,162 |
| 2011-06-30 | $1,112 |
| 2011-03-31 | $1,053 |
| 2010-12-31 | $1,000 |
| 2010-09-30 | $942 |
| 2010-06-30 | $885 |
| 2010-03-31 | $832 |
| 2009-12-31 | $783 |
| 2009-09-30 | $737 |
| 2009-06-30 | $695 |
| 2009-03-31 | $649 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.876B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.058B | 28.41 |
| Boston Scientific (BSX) | United States | $149.209B | 40.19 |
| Stryker (SYK) | United States | $142.084B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $131.854B | 0.00 |
| Medtronic (MDT) | Ireland | $115.249B | 16.83 |
| Haleon (HLN) | United Kingdom | $46.488B | 26.39 |
| Lonza Group Ag (LZAGY) | Switzerland | $44.527B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $36.909B | 17.98 |
| Agilent Technologies (A) | United States | $33.351B | 22.03 |
| Terumo (TRUMY) | Japan | $27.805B | 39.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.874B | 17.05 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.530B | 14.15 |
| Insulet (PODD) | United States | $18.442B | 78.86 |
| Baxter (BAX) | United States | $17.557B | 12.63 |
| Sunny Optical Technology (SNPTF) | China | $12.864B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Demant (WILYY) | Denmark | $8.048B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.822B | 23.62 |
| Lantheus Holdings (LNTH) | United States | $6.684B | 16.43 |
| Prestige Consumer Healthcare (PBH) | United States | $4.259B | 20.32 |
| Perrigo (PRGO) | Ireland | $3.826B | 10.95 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.405B | 29.11 |
| Haemonetics (HAE) | United States | $3.193B | 15.02 |
| Envista Holdings (NVST) | United States | $2.972B | 23.64 |
| QuidelOrtho (QDEL) | United States | $2.359B | 19.76 |
| GN Store Nord (GNNDY) | Denmark | $2.336B | 15.74 |
| LeMaitre Vascular (LMAT) | United States | $1.893B | 43.25 |
| Neogen (NEOG) | United States | $1.881B | 21.67 |
| AtriCure (ATRC) | United States | $1.577B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.462B | 14.08 |
| Kestra Medical Technologies (KMTS) | $1.234B | 0.00 | |
| InMode (INMD) | Israel | $1.234B | 10.31 |
| Green Thumb Industries (GTBIF) | United States | $1.233B | 19.37 |
| BioLife Solutions (BLFS) | United States | $1.073B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.865B | 13.27 |
| Evolus (EOLS) | United States | $0.765B | 0.00 |
| Owens & Minor (OMI) | United States | $0.698B | 5.94 |
| CeriBell (CBLL) | United States | $0.689B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.601B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.562B | 0.00 |
| Valneva SE (VALN) | France | $0.545B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.478B | 20.71 |
| Omeros (OMER) | United States | $0.476B | 0.00 |
| Surmodics (SRDX) | United States | $0.436B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.433B | 0.00 |
| SNDL (SNDL) | Canada | $0.371B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.354B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| ZimVie (ZIMV) | United States | $0.301B | 18.00 |
| Viemed Healthcare (VMD) | United States | $0.288B | 26.00 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Quanterix (QTRX) | United States | $0.252B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 43.90 |
| Verano Holdings (VRNOF) | United States | $0.233B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.184B | 14.19 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Brainsway (BWAY) | Israel | $0.178B | 55.71 |
| TriSalus Life Sciences (TLSI) | United States | $0.168B | 0.00 |
| High Tide (HITI) | Canada | $0.153B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.144B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.140B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.116B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.112B | 13.99 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 12.18 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.067B | 24.44 |
| United Health Products (UEEC) | United States | $0.066B | 0.00 |
| Exagen (XGN) | United States | $0.064B | 0.00 |
| InterCure (INCR) | Israel | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.041B | 12.66 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.50 |
| Safety Shot (SHOT) | United States | $0.027B | 0.00 |
| INLIF (INLF) | $0.021B | 0.00 | |
| Nephros (NEPH) | United States | $0.018B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |